Grantham, Mayo, Van Otterloo & Co. LLC
- SEC CIK
- 0001352662
- Latest filing
- Aug 13, 2026
ELV holding history
Elevance Health, Inc. in every 13F filed by Grantham, Mayo, Van Otterloo & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ELV overviewAll 13F holders of ELVFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,691,671
- Value
- $654.2M
- % of portfolio
- 1.5%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,691,671 | $654.2M | 1.5% | −246,605−12.7% | Reduced | Holders |
| Q1 2026 | 1,938,276 | $564.3M | 1.4% | −592,814−23.4% | Reduced | Holders |
| Q4 2025 | 2,531,090 | $887.3M | 2.3% | +7,640+0.3% | Added | Holders |
| Q3 2025 | 2,523,450 | $815.4M | 2.3% | +483,340+23.7% | Added | Holders |
| Q2 2025 | 2,040,110 | $793.5M | 2.4% | −118,881−5.5% | Reduced | Holders |
| Q1 2025 | 2,158,991 | $939.1M | 3.0% | +158,331+7.9% | Added | Holders |
| Q4 2024 | 2,000,660 | $738.0M | 2.4% | +316,002+18.8% | Added | Holders |
| Q3 2024 | 1,684,658 | $876.0M | 2.7% | +334,790+24.8% | Added | Holders |
| Q2 2024 | 1,349,868 | $731.4M | 2.5% | +102,603+8.2% | Added | Holders |
| Q1 2024 | 1,247,265 | $646.8M | 2.4% | +328,504+35.8% | Added | Holders |
| Q4 2023 | 918,761 | $433.3M | 1.9% | +28,849+3.2% | Added | Holders |
| Q3 2023 | 889,912 | $387.5M | 1.8% | +59,071+7.1% | Added | Holders |
| Q2 2023 | 830,841 | $369.1M | 1.7% | +112,802+15.7% | Added | Holders |
| Q1 2023 | 718,039 | $330.2M | 1.7% | +9,196+1.3% | Added | Holders |
| Q4 2022 | 708,843 | $363.6M | 1.9% | −5,299−0.7% | Reduced | Holders |
| Q3 2022 | 714,142 | $324.4M | 1.9% | −15,466−2.1% | Reduced | Holders |
| Q2 2022 | 729,608 | $352.1M | 1.9% | −202,938−21.8% | Reduced | Holders |
| Q1 2022 | 932,546 | $458.1M | 2.2% | −169,482−15.4% | Reduced | Holders |
| Q4 2021 | 1,102,028 | $510.8M | 2.5% | −39,818−3.5% | Reduced | Holders |
| Q3 2021 | 1,141,846 | $425.7M | 2.1% | +96,566+9.2% | Added | Holders |
| Q2 2021 | 1,045,280 | $399.1M | 2.0% | +10,053+1.0% | Added | Holders |
| Q1 2021 | 1,035,227 | $371.6M | 2.0% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.